Google launches health research app To view this email as a web page,
click here Pfizer’s COVID vaccine data raise some flags, analysts say, but not enough to scuttle an FDA nod AstraZeneca COVID-19 vaccine data hint at single-dose efficacy, effect on asymptomatic cases Google moves into health research with mobile app, starting with respiratory illnesses like COVID Biopharma roundup: Pfizer shot wins nod in Canada Roche to supply antibody tests to Moderna's COVID-19 vaccine trial CVS, Walgreens execs: 'Immunizations are core to what we do' Care New England appears to decline StoneBridge Healthcare purchase offer of $550M Featured Story | By Arlene Weintraub A few surprises cropped up in FDA documents released ahead of an advisory committee meeting on Pfizer's COVID-19 vaccine candidate, including some side effects reported in the phase 3 trial. They'll trigger discussion at Thursday's confab, but not enough alarm to prevent a quick emergency authorization, analysts predicted. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a single dose and prevent asymptomatic cases but left key questions about the efficacy of the candidate unanswered. read more By Heather Landi Google is upping its focus on health research with a new mobile app that lets smartphone users participate in virtual health studies. The tech giant is going up against competitor Apple, which has made strides in remote research efforts since rolling out its first virtual health study in 2017. Here's what Google Health is focusing on with its remote health studies. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner Canada became the third country to authorize Pfizer's vaccine. Europe's drug regulator was the victim of a cyberattack. President-elect Biden plans to vaccinate 100 million Americans during his early days in office. In the push to allocate vaccines, states disagree on who's essential. Plus, Indonesia received its first shipment of Sinovac shots. read more By Conor Hale The partnership aims to draw the line where antibody protection begins, and provide answers on whether booster shots will be needed to maintain immunity. read more By Tina Reed Top execs from national retail pharmacy chains CVS and Walgreens say their infrastructure is ready and well-tested for the challenges ahead in distributing the COVID-19 vaccines once they become available. read more By Robert King Care New England Heath System appeared to decline a purchase offer from StoneBridge Healthcare as it continues merger talks with Lifespan. read more |
|
